Mycobacterium avium-intracellulare Infection
"Mycobacterium avium-intracellulare Infection" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nontuberculous infection when occurring in humans. It is characterized by pulmonary disease, lymphadenitis in children, and systemic disease in AIDS patients. Mycobacterium avium-intracellulare infection of birds and swine results in tuberculosis.
| Descriptor ID |
D015270
|
| MeSH Number(s) |
C01.252.410.040.552.475.495
|
| Concept/Terms |
Mycobacterium avium-intracellulare Infection- Mycobacterium avium-intracellulare Infection
- Mycobacterium intracellulare Infection
- Mycobacterium avium intracellulare Infection
- Infection, Mycobacterium avium-intracellulare
- Infection, Mycobacterium avium intracellulare
- Infections, Mycobacterium avium-intracellulare
- Mycobacterium avium-intracellulare Infections
- Infection, Mycobacterium intracellulare
- Infections, Mycobacterium intracellulare
- Mycobacterium intracellulare Infections
|
Below are MeSH descriptors whose meaning is more general than "Mycobacterium avium-intracellulare Infection".
Below are MeSH descriptors whose meaning is more specific than "Mycobacterium avium-intracellulare Infection".
This graph shows the total number of publications written about "Mycobacterium avium-intracellulare Infection" by people in this website by year, and whether "Mycobacterium avium-intracellulare Infection" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mycobacterium avium-intracellulare Infection" by people in Profiles.
-
Time-to-positivity of Mycobacterium avium complex in broth culture associates with culture conversion. BMC Infect Dis. 2022 Mar 12; 22(1):246.
-
Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial. Ann Am Thorac Soc. 2021 07; 18(7):1147-1157.
-
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure. Chest. 2021 09; 160(3):831-842.
-
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study. Am J Respir Crit Care Med. 2018 12 15; 198(12):1559-1569.
-
A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states. J Immunol. 2004 Sep 15; 173(6):4000-8.
-
Isolated intracranial infection with Mycobacterium avium complex. J Neurosurg Sci. 2003 Jun; 47(2):101-5; discussion 105.
-
Adjunctive corticosteroid therapy for patients whose treatment for disseminated Mycobacterium avium complex infection has failed. Clin Infect Dis. 1998 Mar; 26(3):682-6.
-
Evaluating the quality of life associated with rifabutin prophylaxis for Mycobacterium avium complex in persons with AIDS: combining Q-TWiST and multiattribute utility techniques. Qual Life Res. 1995 Aug; 4(4):309-18.
-
Medicine's arsenal in battling 'dominant dozen,' other AIDS-associated opportunistic infections. JAMA. 1991 Sep 18; 266(11):1476-8, 1481.